These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix. Costa S, Negri G, Sideri M, Santini D, Martinelli G, Venturoli S, Pelusi C, Syrjanen S, Syrjanen K, Pelusi G. Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701 [Abstract] [Full Text] [Related]
5. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C. Clin Infect Dis; 2005 Feb 01; 40(3):451-7. PubMed ID: 15668870 [Abstract] [Full Text] [Related]
6. PCR detection rates of high risk human papillomavirus DNA in paired self-collected urine and cervical scrapes after laser CO2 conization for high-grade cervical intraepithelial neoplasia. Fambrini M, Penna C, Pieralli A, Bussani C, Fallani MG, Andersson KL, Scarselli G, Marchionni M. Gynecol Oncol; 2008 Apr 01; 109(1):59-64. PubMed ID: 18255129 [Abstract] [Full Text] [Related]
7. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W. BJOG; 2006 Nov 01; 113(11):1303-7. PubMed ID: 16978225 [Abstract] [Full Text] [Related]
8. Testing for high risk human papilloma virus in the initial follow-up of women treated for high-grade squamous intraepithelial lesions. Smart OC, Sykes P, Macnab H, Jennings L. Aust N Z J Obstet Gynaecol; 2010 Apr 01; 50(2):164-7. PubMed ID: 20522074 [Abstract] [Full Text] [Related]
9. Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction. Herfs M, Somja J, Howitt BE, Suarez-Carmona M, Kustermans G, Hubert P, Doyen J, Goffin F, Kridelka F, Crum CP, Delvenne P. Int J Cancer; 2015 Mar 01; 136(5):1043-52. PubMed ID: 24839092 [Abstract] [Full Text] [Related]
10. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Baloglu A, Uysal D, Bezircioglu I, Bicer M, Inci A. Arch Gynecol Obstet; 2010 Jul 01; 282(1):69-73. PubMed ID: 19940997 [Abstract] [Full Text] [Related]
11. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins. Wu D, Zheng Y, Chen W, Guo C, Yu J, Chen G, Huang Y. Aust N Z J Obstet Gynaecol; 2011 Apr 01; 51(2):114-8. PubMed ID: 21466511 [Abstract] [Full Text] [Related]
12. Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation. Heymans J, Benoy IH, Poppe W, Depuydt CE. Int J Cancer; 2011 Aug 15; 129(4):903-9. PubMed ID: 21064091 [Abstract] [Full Text] [Related]
13. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus]. Bekkers RL, Hanselaar AG, Melchers WJ, van Schaik JH, Boonstra H, Massuger LF. Ned Tijdschr Geneeskd; 2003 Feb 15; 147(7):302-6. PubMed ID: 12622008 [Abstract] [Full Text] [Related]
14. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjänen S, Syrjänen K. Gynecol Oncol; 2003 Aug 15; 90(2):358-65. PubMed ID: 12893200 [Abstract] [Full Text] [Related]
15. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia. Spinillo A, Dominoni M, Boschi AC, Cesari S, Fiandrino G, Gardella B. Gynecol Oncol; 2020 Dec 15; 159(3):630-635. PubMed ID: 33041069 [Abstract] [Full Text] [Related]
16. Human papillomavirus combined with cytology and margin status identifies patients at risk for recurrence after conization for high-grade cervical intraepithelial neoplasia. Ruano Y, Torrents M, Ferrer FJ. Eur J Gynaecol Oncol; 2015 Dec 15; 36(3):245-51. PubMed ID: 26189247 [Abstract] [Full Text] [Related]
17. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Chao A, Lin CT, Hsueh S, Chou HH, Chang TC, Chen MY, Lai CH. Am J Obstet Gynecol; 2004 Apr 15; 190(4):1046-51. PubMed ID: 15118639 [Abstract] [Full Text] [Related]
18. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis. Bodner K, Bodner-Adler B, Wierrani F, Kimberger O, Denk C, Grünberger W. Anticancer Res; 2002 Apr 15; 22(6B):3733-6. PubMed ID: 12552985 [Abstract] [Full Text] [Related]
19. [Early human papillomavirus testing predicts residual/recurrent disease after LEEP risk factors for predicting residual disease in high-grade squamous cervical intraepithelial neoplasia following LEEP conization]. Niu XY, Feng YK. Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar 15; 46(2):321-5. PubMed ID: 25924452 [Abstract] [Full Text] [Related]
20. Correlation of recurrence rates and times with posttreatment human papillomavirus status in patients treated with loop electrosurgical excision procedure conization for cervical squamous intraepithelial lesions. Prato B, Ghelardi A, Gadducci A, Marchetti I, Di Cristofano C, Di Coscio G, Bevilacqua G, Genazzani AR. Int J Gynecol Cancer; 2008 Mar 15; 18(1):90-4. PubMed ID: 17506849 [Abstract] [Full Text] [Related] Page: [Next] [New Search]